Onychomycosis is one of the most prevalent infectious diseases worldwide, affecting hundreds of millions of people. Yet it remains largely undertreated due to the limited efficacy of topical therapies, long treatment durations, and the side effects of systemic medication. Too many patients abandon treatment or live for years with discomfort, stigma, and recurring infection.

Our mission is to transform the treatment of onychomycosis through technology-driven and personalized solutions. By combining medical device innovation with clinical expertise, we are developing next-generation nail orthoses that enhance local antifungal delivery directly where it is needed. Our approach aims to improve treatment efficacy, increase patient adherence, reduce reliance on systemic drugs, and ultimately lower recurrence rates.

Onicor bridges biomedical engineering and medical mycology to address one of the largest untreated infectious diseases globally.

We are committed to bringing safe and effective solutions to patients and healthcare providers worldwide, redefining how fungal nail infections are treated.